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Monocyte adhesion to mesangial matrix modulates cytokine Accumulation of monocytes within the glomerular mes-
and metalloproteinase production. angium is a recognized feature of glomerular injury in
Background. Monocytes migrate into the glomerular mes- humans and characterizes the early stages of glomerularangium during acute inflammatory renal disease, differentiate
scarring in experimental models [1–5]. In human glomer-into macrophages, and may play a key role in the development
ular disease, monocyte/macrophage numbers correlateand progression of glomerular scarring. Treatment strategies
that inhibit monocyte infiltration ameliorate glomerular injury with the extent of histologic damage at the time of biopsy
in animal models. Mesangial matrix contains several potential and predict renal outcome in certain disease settings
monocyte-binding domains that may contribute to monocyte
[6, 7]. Macrophages expressing activation and prolifera-entrapment and modulate cell activation.
tion markers have been identified in more aggressiveMethods. Adhesion of peripheral blood-derived monocytes
to matrix synthesized by human mesangial cells and to individual forms of human and experimental glomerulonephritis
matrix proteins was assessed by colorimetry of nuclear staining and correlate with disease severity [8–10]. Although the
with crystal violet. Monoclonal antibodies were used to identify mechanisms of macrophage trafficking and activationthe cell-surface integrins and matrix ligands involved. Mono-
within the glomerulus are not properly understood, itcyte proliferation was assessed by 3H-thymidine incorporation
is generally assumed that these cells are derived fromand cytokine production using enzyme-linked immunosorbent
assay (ELISA). Secretion of metalloproteinases and their in- circulating monocytes that migrate from the glomerular
hibitors was determined by zymography and ELISA, respec- capillary lumen. During this process the monocyte en-
tively.
counters many extracellular signals that promote differ-Results. Monocytes bound to matrix synthesized by mesan-
entiation to a macrophage and other cellular responses.gial cells. Prestimulation of mesangial cells with tumor necrosis
factor- (TNF-) and transforming growth factor- (TGF-) Recent studies suggest that such interactions may pro-
enhanced matrix fibronectin content (P 0.001) and monocyte gram macrophages, thereby potentially modifying their
binding (P 0.001). Blocking antibodies to fibronectin, as well behavior in the setting of acute or chronic glomerularas to the integrins very late antigen-4 (VLA-4) and VLA-5, re-
disease [11]. For example, external stimuli may deter-duced monocyte adhesion to mesangial matrix by approxi-
mine production of inflammatory cytokines such as tu-mately 50%. Incubation of monocytes with matrix, fibronectin,
laminin and collagen IV enhanced production of interleu- mor necrosis factor- (TNF-), interleukin-1 (IL-1)
kin-1 (IL-1), interleukin-6 (IL-6), TNF- and metallopro- and interleukin-6 (IL-6), as well as metalloproteinase-9
teinase-9 (MMP-9) when compared to cells incubated in plastic
(MMP-9) and tissue inhibitors of metalloproteinaseswells. However, there was no apparent difference in prolifera-
(TIMPs), which modulate matrix turnover.tion rate and no change in production of metalloproteinase
inhibitors. Blocking signaling pathways that determine mono-
Conclusion. Monocyte activation within the glomerulus may cyte/macrophage function represents an attractive target
be mediated by binding to mesangial matrix components, par- for therapeutic intervention. Such strategies have beenticularly fibronectin. Matrix-mediated activation enhances pro-
evaluated in animal models of acute glomerulonephritis.duction of inflammatory cytokines and matrix-degrading en-
For example monoclonal antibodies directed againstzymes.
leukocyte function-associated antigen-1 (LFA-1) and
its endothelial ligand, intercellular adhesion molecule-1Key words: monocytes, mesangial cell matrix, fibronectin, cytokines,
glomerulosclerosis. (ICAM-1) were found to block monocyte trafficking and
inhibit glomerular injury in rats given nephrotoxic serum
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ing the number of infiltrating cells, while blockade of buffered saline (PBS), resuspended in RPMI medium
vascular cell adhesion molecule-1 (VCAM-1), a major containing 10% FCS and the cells plated into Petri dishes
ligand of VLA-4, had no effect [13]. These results suggest overnight. The nonadhered monocytes were removed by
that binding of VLA-4 to an alternative ligand within the washing six times with 0.15 mol/L sodium chloride
glomerulus may be important in modulating monocyte (NaCl) and those that had adhered were incubated in
function in the context of glomerular injury. Since our 0.15 mol/L NaCl containing 0.3 mmol/L ethylenediamine-
previous studies demonstrated that adhesion of mono- tetraacetic acid (EDTA) for 45 minutes at 4oC. These
cytes to activated mesangial cells was mediated, at least cells were removed using a cell scraper (Falcon, Cowley,
in part, by cell-associated fibronectin [14], we postulated UK), collected into universal containers, pelleted by cen-
that this matrix component may be an important ligand. trifugation, resuspended in RPMI medium containing
The following experiments were designed to test the 10% FCS and counted using a hemacytometer.
hypothesis that interactions with mesangial matrix mod-
Flow cytometry analysis of monocytesulated the secretory function of monocyte/macrophages.
While initial studies involved the use of monocytes de- Both peripheral blood and U-937 monocytes were as-
rived from peripheral blood samples collected from sessed for expression of early (CD69) and late [human
healthy volunteers, we were able to demonstrate that lymphocyte antigen (HLA-DR)] cell-surface activation
U-937 monocytic cells exhibited similar characteristics markers. Briefly, 200L monocyte cell suspension (1.0
in terms of matrix binding and therefore used this cell 106 cells/mL) was aliquoted and centrifuged at 400 g for
line in many of the subsequent experiments, validating 5 minutes. The pellet was resuspended in 80 L PBS/10%
results against those obtained with peripheral blood FCS /0.1% sodium azide. Then, 10 L anti-CD14 antibody
monocytes as appropriate. The results indicate that ma- coupled to fluorescinisothiocyanate (FITC) (Becton Dick-
trix may promote mononuclear cell accumulation within inson, Cowley, UK) together with 10 L of either anti-
the mesangium, and that interactions between mono- CD69 antibody coupled to phycoerythrin (PE) (Becton
cytes and matrix components (particularly fibronectin) Dickinson) or anti-HLA-DR PE antibody (Becton Dick-
promote secretion of monocyte products that may poten- inson) was added and samples incubated in the dark at
tially modify disease outcome. room temperature for 30 minutes. Cells were then
washed with PBS containing 1% bovine serum albumin
METHODS (BSA) and fixed for flow cytometric analysis in equal
amounts of PBS/10% FCS/0.1% NaN3 and 2% para-Cell preparation
formaldehyde solution. Data were acquired on a FACSHuman mesangial cells were established in culture as
440-flow cytometer using an argon ion laser at 488 nm.previously described [15]. Briefly, glomeruli separated
FITC fluorescence was assessed using a 530 nm  15from cortical tissue by differential sieving were collagen-
nm filter and PE using a 575 nm 15 nm filter. Collectedase digested and plated in RPMI medium supplemented
data were edited and analyzed using in-house software.with 20% fetal calf serum (FCS), l-glutamine (300g/mL),
insulin (5g/mL), transferrin (5g/mL), selenium (5 ng/mL), Immunohistochemical labeling
penicillin (100 IU/mL), and streptomycin (100 g/mL). Mes-
These studies were designed to confirm that matrixangial cells were subcultured into multiwell plates and
preparations were free of mesangial cells and containedused between passages 3 and 10. The characterization
fibronectin. Human mesangial cells were grown on glassof these cells has been described in detail elsewhere [16].
cover slips, then removed as described below. The re-Human myelomonocytic leukemia cells of the U-937
maining material was fixed with 100% ethanol and ex-cell line (European Collection of Cell Culture, Salisbury,
posed to a mouse monoclonal antihuman fibronectin an-UK) were grown in supplemented RPMI 1640 medium
tibody for 30 minutes at room temperature. Cells andas above. Cultures were expanded by seeding approxi-
matrix were then exposed to a bridging rabbit antimousemately 2  106 cells into 15 mL 20% FCS supplemented
antibody for 1 hour, followed by an alkaline phospha-RPMI medium in T75 culture flasks (Falcon Scientific
tase-conjugated mouse anti-alkaline phosphatase com-Supplies, London, UK) and fed every 4 days. Before adhe-
plex. After rinsing, the cover slips were developed usingsion assays, cells were centrifuged at 180 g for 5 minutes.
fast red for 5 minutes and counterstained for nuclei withThe monocyte pellet was rinsed twice in RPMI medium
Mayer’s acid alum hematoxylin.and was resuspended to a known cell concentration in
the experimental incubation medium.
Scanning electron microscopyPeripheral blood mononuclear cells were isolated
To further confirm that the matrix preparation was freefrom venous blood collected from healthy volunteers by
of mesangial cells and supported monocyte adhesion,centrifugation over Ficoll-Hypaque (Pharmacia Biotech
scanning electron microscopy was undertaken. After re-AB, Uppsala, Sweden) at 400 g for 30 minutes. The
lymphocyte layer was collected, washed with phosphate- moving cells from the underlying matrix or following
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incubation of monocytes with matrix, the matrix was sorbance readings recorded at 595 nm. The results ob-
washed three times with PBS to remove either the free tained were corrected by the subtraction of background
cells or nonadherent monocytes. The samples were then staining of the underlying matrix. The corrected values
fixed in 3% phosphate-buffered glutaraldehyde and 1% were then taken to be proportional to the number of
aqueous osmium tetraoxide. Specimens were dehydrated monocytes bound to matrix.
through a gradual series of ethanol washes and finally To confirm the role of fibronectin and specific monocyte
by critical point drying in liquid carbon dioxide (CO2), integrins in the binding process, antihuman fibronectin
using a Polaron E300 critical point drying apparatus. The (25g/mL, Sigma), anti-VLA-4 (10g/mL, AMS Biotech-
samples were then sputter coated with gold-palladium nology, Abingdon, Oxon, UK) and anti-VLA-5 (5 g/ml,
in a Polaron E5100 series II coating system and examined AMS Biotechnology) antibodies were used in blocking
using a JEOL JSM-5300 scanning electron microscope. experiments. In each case, the optimal antibody concen-
tration (shown above) was chosen on the basis of prelimi-Fibronectin assay
nary experiments using a range of dilutions. The antihu-
The synthesis of fibronectin by mesangial cells was mea- man fibronectin antibody was preincubated with matrix
sured by enzyme-linked immunosorbent assay (ELISA) while either U-937 and peripheral blood–derived mono-
(R&D Systems, Abingdon, Oxon, UK) [17]. After wash-
cytes were pre-exposed to the anti-integrin antibodies for
ing, the cell layer was solubilized overnight in wash buffer
1 hour at room temperature prior to the adhesion assays.(0.3 mmol/L NaCl, 0.1% Triton X-100 in PBS) containing
1% P40. The standards and appropriately diluted cell Cytokine production
layer extracts were then incubated overnight in wells that
IL-1, IL-6, and TNF- secreted by peripheral blood–had been precoated with a rabbit polyclonal antihuman
derived monocytes following exposure to matrix and in-fibronectin antibody (1:1000, Sigma Chemical Co., Poole,
dividual protein components were measured by ELISA.Dorset, UK). This was followed by the addition of a mouse
Briefly, monocytes (0.5  106 cells/mL) were added tomonoclonal antihuman fibronectin (1:500, Sigma) and a
24 multi-well plates containing mesangial matrix or tohorseradish peroxidase–conjugated antimouse antibody
empty plastic wells for 24 hours. Alternatively, solubi-(1:1000, Dako, Ltd., Ely, Cambridgeshire, UK) for 2 hours
lized matrix, fibronectin, laminin, and collagen IV wereeach. Plates were then developed using a phenylenedia-
added to monocytes preplated in 24 well plates. Formine substrate. After the color had appeared, the reac-
positive and negative controls, monocytes were incu-tion was stopped by adding 1 mol/L sulphuric acid and
bated in plastic wells for 24 hours with or without lipo-the absorbance recorded at 492 nm. All fibronectin con-
centrations were measured as nanograms per milliliter and polysaccharide (LPS, 10 g/mL), respectively. In each
then expressed as % of control (growth arrested cells). case, the resulting conditioned medium was collected by
spinning at 6500 rpm for 5 minutes in a microfuge. Sam-
Adhesion assay ples were stored at 80C prior to the analysis. All re-
The binding of U-937 and peripheral blood–derived agents and materials used in the experiments, including
monocytes to mesangial matrix was determined using a matrix, matrix components, and buffers, were tested for
colorimetric method as described by Mene´ et al [18]. endotoxin contamination using a Limulus amebocyte ly-
Briefly, mesangial cells plated at a density of 25,000 cells/ sate test kit (Sigma) and proved negative.
well in 24 well plates were grown for 96 hours, then
growth arrested for 48 hours in serum-free medium. To Thymidine incorporation
determine the impact of matrix accumulation, mesangial The ability of mesangial cell matrix to induce prolifera-
cells were prestimulated with TGF- (10 ng/mL), TNF-
tion of blood-derived and U-937 monocytes was assayed
(10 ng/mL) or a combination of both cytokines for 48
by measuring the incorporation of 3H-thymidine. Briefly,hours. After thorough washing, the cell layer was re- 3H-thymidine (3.6 Ci/mL) was added to peripheralmoved by adding 2.5 mmol/L NH4OH and 0.1% Triton
blood–derived (0.25 106 cells/mL) or U-937 monocytesX-100 for 10 minutes as described by Weiss and Regiani
(1.25 106 cells/mL) plated on matrix or in empty plastic[19], leaving behind the cell matrix, which was also
culture plates for up to 96 hours. At the end of thewashed extensively. Monocytes (2  106 cells/well) were
incubation period, the adherent and nonadherent cellsthen incubated with the residual matrix produced by
were collected, washed with PBS, and treated with 50%the prestimulated or nonstimulated mesangial cells for
methanol containing 10% glacial acetic acid followed by1 hour at 37oC in serum-free medium. Nonadhered
10% trichloroacetic acid. After further washes, the cellsmonocytes were removed by washing. Adhered cells
were solubilized in 0.1 mol/L NaOH containing 1% so-were fixed with 1.0% glutaraldehyde and stained with a
dium dodecyl sulfate (SDS) and the radioactivity incor-crystal violet solution [0.1% (w/v)]. Cells were washed,
solubilized overnight in Triton X-100 (1.0%), and ab- porated determined by liquid scintillation counting.
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Gelatinolytic activity
The secretion of gelatinolytic enzymes by peripheral
blood–derived monocytes incubated with mesangial cell
matrix and matrix proteins was determined by zymogra-
phy as previously described [16]. Briefly, mesangial cells
grown in 24 well plates were removed from the underly-
ing matrix and incubated with human monocytes (0.5 
106 cells/mL) for 24 hours in the absence of FCS. The
resulting conditioned medium was isolated, centrifuged
and stored at 80C for batch analysis. The enzyme
activity of MMP-9 was assessed by SDS-polyacrylamide
gel electrophoresis (PAGE) using a 7.5% gel, incorpo-
rating gelatin (1 mg/mL), under nonreducing conditions
[16]. Following electrophoresis, the gel was washed with
2.5% Triton X-100 for 1 hour and incubated in 50
mmol/L Tris HCl pH 7.6 containing CaCl2 (10 mmol/L)
and Brij (0.05%) at 37C overnight. The gel was then
fixed, stained with Coomassie blue and enzymatic activ-
ity demonstrated by zones of lysis and quantified by
densitometry.
Analysis of TIMP I and TIMP II
Concentrations of TIMP I and TIMP II secreted by
blood-derived monocytes into conditioned medium were
measured by ELISA [20, 21]. Standards of TIMP I (0.15
to 150 ng/mL) and TIMP II (0.15 to 300 ng/mL) were
prepared using purified TIMP kindly supplied by Profes-
sor T. E. Cawston (Department of Medicine, University
of Newcastle, United Kingdom). Antibodies to TIMP
were kindly provided by Dr. A. Docherty, Cell Tech,
Fig. 1. Electron and light micrographs of mesangial matrix. (A ) TheSlough, and Dr. G. Murphy, University of East Anglia, cell layer was removed from the underlying matrix by adding 2.5 mmol/L
NH4OH and 0.1% Triton X-100. The matrix was then fixed and preparedNorwich, United Kingdom.
for electron microscopy as described in the Methods section. Bar 	
1 m, original magnification 5000. (B ) U-937 monocytes adherent toStatistical analysis
cell matrix. U-937 monocytes were incubated with matrix for 1 hour.
After washing, adherent monocytes were fixed and stained with crystalStatistical analysis was performed using a Mann-Whit-
violet as described in the Methods section and visualized under a lightney unpaired nonparametric two-tailed test or where
microscope. Original magnification 100.
indicated by paired Student t test. Results are expressed
as mean  SEM unless otherwise stated and P  0.05
was considered significant.
The cell-associated fibronectin was further increased to
256.7% (3.9%, P  0.001) when a combination of 10
RESULTS ng/mL of TNF- and 10 ng/mL TGF- was added, sug-
Matrix composition gesting that these cytokines had a synergistic effect on
matrix synthesis. TNF- alone had little effect on cell-Staining studies demonstrated that after solubilization
associated fibronectin production (114.5%  4.1%, P 	of mesangial cells, no nuclear material remained and that
NS). In four separate experiments, each one carried outfibronectin was present in the residual matrix. Electron
in triplicate, matrix was found to contain very low con-microscopy confirmed an absence of cellular debris (Fig.
centrations of TGF- ( 0.05 pg/g) and virtually un-1A). In keeping with previous published work, prestimu-
detectable amounts of TNF- ( 0.02 pg/g), IL-1lation of mesangial cells with TGF- alone and in combi-
(0.003 pg/g), and IL-6 ( 0.003 pg/g).nation with TNF- led to increased fibronectin produc-
tion (data not shown) [22]. At a concentration of 10
Monocyte characteristicsng/mL, TGF- increased cell-associated fibronectin to
U-937 and peripheral blood–derived monocytes recov-127.8%  10.1% (P  0.05) (mean  SEM) compared
to control cells grown in serum-free medium (100%). ered after 24 hours’ incubation on tissue culture plastic
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Fig. 2. Adhesion of U-937 monocytes to matrix synthesized by mesan-
gial cells prestimulated with transforming growth factor- (TGF-),
tumor necrosis factor- (TNF-), and TGF- 
 TNF-. Monocytes
were incubated for 1 hour with matrix after removal of mesangial cells.
Adherent monocytes were fixed, stained, solubilized, and quantified
by colorimetry. The mean (SEM) of triplicate absorbance readings,
corrected for background staining of matrix, is expressed as a percentage
of control (matrix arising from unstimulated cells). The results are
representative of those obtained in four experiments. *P  0.05, **P 
0.001 vs. control.
plates possessed both early (CD69) and late (HLA-DR)
monocyte surface markers. There was no change in the
expression of either cell marker, even after the cells were
Fig. 3. Inhibition of U-937 monocyte adhesion to matrix produced bycultured on matrix or plastic for up to 72 hours. unstimulated mesangial cells (A ) or mesangial cells prestimulated with
TGF-/TNF- (B ). The matrix was preincubated with antifibronectin
Adherence of monocyte to mesangial cell matrix (25 g/mL) antibody for 2 hours before a suspension of U-937 mono-
cytes was added. Alternatively, monocytes were preincubated with anti-Both U-937 and peripheral blood–derived monocytes VLA-4 (10 g/mL) and anti-VLA-5 (5 g/mL) antibodies for 1 hour
adhered strongly to matrix synthesized by mesangial cells before being added to matrix. After washing, adherent monocytes were
fixed, stained with crystal violet, solubilized, and quantified by densitom-grown under standard conditions, following the removal
etry. The results are expressed as mean (SEM) absorbance, corrected
of the mesangial cells (Fig. 1B). Binding occurred pre- for the background staining of matrix, and expressed as a percentage
of control (100%). These results are a representative of four experi-dominantly to the matrix itself, with minimal adhesion
ments; each conducted in triplicate at optimal antibody concentrations.to the uncoated plastic plate. Using U-937 cells, we dem-
*P  0.005 vs. control; **P  0.0001 vs. control.
onstrated that prestimulation of mesangial cells with
TGF- and TNF- led to increased monocyte binding
to the residual matrix (Fig. 2). Compared to control
matrix (i.e., that produced by cells exposed to serum-
ing to matrix synthesized by TGF-/TNF- prestimu-free medium alone, 100% binding), binding of U-937
lated mesangial cells was reduced by anti-VLA-5 anti-cells to matrix synthesized by cells prestimulated with
body to 44.8% 2.5% (P 0.0001) (Fig. 3B). Once again,TGF- and TNF- was increased by 127.5%  17.7%,
a reduction in binding was observed when matrix from(P  0.05) and 123.6%  9.7% (P  0.05), respectively.
non-prestimulated mesangial cells was primed with anti-When a combination of the two cytokines was used,
VLA-4 antibody, but not with antifibronectin antibodybinding increased to 188.0%  5.5% (P  0.001) com-
(Fig. 3A). Anti-VLA-4 and antifibronectin antibodiespared to control matrix.
also reduced monocyte adhesion to matrix produced by
Inhibition of monocyte adhesion to matrix TGF-/TNF- prestimulated mesangial cells to 54.9% 
4.9% (P  0.0001) and 56.6%  5.6% (P  0.0001),Antibodies directed against VLA-4 and VLA-5 integ-
respectively, compared to control (Fig. 3B). In a compara-rins reduced U-937 monocyte binding to mesangial ma-
tive experiment, binding of peripheral blood–derivedtrix when compared to control (no antibody, 100%)
monocytes to mesangial matrix synthesised by non-pre-(Fig. 3). For example, using non-prestimulated mesangial
stimulated mesangial cells was inhibited by 61.5% cells, anti-VLA-5 antibody reduced monocyte binding
4.3% and 58.5%  3.6% by anti-VLA-4 and anti-VLA-5to 78.4%  6.0% (P  0.005) (Fig. 3A) when compared
to control matrix (no antibody, 100%). In contrast, bind- antibodies, respectively.
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there was a 226-fold increase following LPS stimulation
(124.7 pg/mL  15.26 pg/ml, P  0.001). Similar results
were obtained when the production of IL-6 and TNF-
was examined. There were approximately 37-fold and
6-fold increases in IL-6 and TNF- production by mono-
cytes bound to matrix when compared to control cells
incubated in plastic wells. These increases in cytokine
levels cannot be attributed to the change in monocyte
cell number. Proliferation studies using 3H-thymidine
showed similar radiolabel incorporation into U-937 and
peripheral blood–derived monocytes incubated on either
matrix or plastic culture plates (data not shown).
Like whole matrix, individual matrix proteins stimu-
lated cytokine production but differed in terms of the
magnitude of this effect. For example, there was approxi-
mately a 19-fold increase in IL-1when peripheral blood–
derived monocytes were incubated with fibronectin (100
g/mL, P  0.005) when compared to control (mono-
cytes incubated in plastic wells) (Fig. 5A). In contrast,
collagen type IV and laminin increased cytokine produc-
tion by approximately 14- and 5-fold, respectively. This
compared to a 9-fold increase when solubilized whole
matrix was added at the same concentration. These pro-
teins also stimulated monocyte IL-6 and TNF- secretion
(Fig. 5B and C) with a similar pattern of response.
Effects of antibodies on cytokine production
The secretion of cytokines by peripheral blood–derived
monocytes was mimicked by incubation with anti-integ-
rin antibodies. For example, incubation of monocytes in
plastic culture plates with anti-VLA-4 (10 g/mL) and
anti-VLA-5 (5 g/mL) antibodies increased IL-1 pro-
duction compared to control monocytes in medium alone
(see Table 1). Similarly, TNF- secretion was increased
by both antibodies when compared to control.
Mesangial cell matrix stimulation of MMP release
Fig. 4. Interleukin-1 (IL-1) (A ), interleukin-6 (IL-6) (B ) and tumor Incubation with mesangial matrix resulted in increased
necrosis factor- (TNF-) (C ) production by peripheral blood–derived
peripheral blood–derived monocyte MMP-9 secretionmonocytes cultured in the presence of mesangial cell matrix. Peripheral
blood–derived monocytes (0.5  106 cells/mL) were incubated with (Fig. 6A). Densitometric analysis showed a 2.4-fold rise
mesangial cell matrix for 24 hours. For positive and negative controls, in MMP-9 activity compared to control (Fig. 6B). In
monocytes were incubated in plastic wells with or without 10 g/mL
contrast, matrix had no effect on the release of monocytelipopolysaccharide (LPS), respectively. The resulting conditioned me-
dium was collected and spun and cytokines were measured by enzyme- MMP-2 (data not shown). Addition of matrix proteins
linked immunosorbent assay. Results are mean  SEM of four experi- also led to increased activity of monocyte MMP-9. The
ments, each performed in quadruplicate. *P  0.001 vs. control.
response to fibronectin was dose-dependent (Fig. 7).
Effect of matrix and soluble proteins on monocyte
TIMP secretionAdhesion to mesangial matrix stimulates monocyte
cytokine secretion Matrix did not stimulate peripheral blood–derived
monocyte TIMP I or TIMP II secretion (Table 2), norAdhesion of peripheral blood–derived monocytes to
was there any effect seen with addition of fibronectinmesangial matrix led to an increase in the production of
(data not shown). The effect of anti-VLA-4 and anti-IL-1 by 14-fold when compared to control monocytes
VLA-5 antibodies on monocyte secretion of metallopro-incubated in plastic wells (7.74 pg/mL  1.25 pg/mL vs.
0.55 pg/mL 0.23 pg/mL, P 0.001) (Fig. 4). In contrast, teinases or their inhibitors was not investigated.
Chana et al: Monocyte adhesion to mesangial cell matrix 895
Table 1. Production of cytokines by human monocytes
exposed to anti-VLA-4 (10 g/mL) and anti-VLA-5
(5 g/mL) antibodies for 24 hours
Antibody IL-1 pg/mL P value TNF pg/mL P value
Control 2.02.4 — 64.26.0 —
Anti-VLA-4 45.412.0 0.005 2649.6424.2 0.0001
Anti-VLA-5 93.313.5 0.0001 3551.7458.4 0.0001
0.05* 0.005*
Cytokines were measured in the conditioned medium by enzyme-linked immu-
nosorbent assay (ELISA) as described in the Methods section. Results are
meanSEM of four experiments, each performed in triplicate or quadruplicate.
Statistical analysis was performed using a paired Student t test. P vs. control;
*P vs. anti-VLA-4.
Fig. 6. Matrix metalloproteinase (MMP) released by monocytes cul-
tured in the presence of mesangial cell matrix. (A ) Peripheral blood–
derived monocytes (0.5  106 cells/mL) were incubated with mesangial
cell matrix for 24 hours in the absence of fetal calf serum. For controls,
monocytes were incubated in plastic wells with or without 10 g/mL
lipopolysaccharide (LPS). The resulting conditioned medium was col-
lected, spun and analyzed by zymography. Results are representative
of five experiments. (B) Densitometric evaluation of zymograms shows
the relative change in metalloproteinase (MMP) secretion compared
to control (100%).
Fig. 5. Interleukin-1 (IL-1) (A ), interleukin-6 (IL-6) (B ) and tumor DISCUSSION
necrosis factor- (TNF-) (C ) production by monocytes cultured in
This study demonstrates that monocytes specificallythe presence of soluble matrix and its protein components. Peripheral
blood–derived monocytes (0.5  106 cells/well) were incubated with bind to mesangial matrix and to its component proteins,
solubilized mesangial cell matrix (100g/well) or its protein components including fibronectin and to a lesser extent collagen type
(100g/well) for 24 hours. For positive and negative controls, monocytes
IV and laminin. Monocyte binding to whole matrix iswere incubated in plastic wells with or without 10g/mL lipopolysaccha-
ride (LPS), respectively. The resulting conditioned medium was col- mediated, at least in part, by fibronectin. An increase in
lected and spun and cytokines were measured by enzyme-linked immu- monocyte binding to mesangial matrix was shown tonosorbent assay. Results (mean  SD) are representative of four
accompany the enhanced synthesis and secretion of fi-experiments, each performed in quadruplicate. *P 0.005 vs. control.
bronectin induced by cytokine prestimulation of mesan-
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Table 2. Release of tissue inhibitors of metalloproteinases by
human monocytes incubated on plastic culture plates (control), with
mesangial cell matrix, and lipopolysaccharide (LPS) for 24 hours




Tissue inhibitors of metalloproteinases (TIMP I and II) were measured in the
conditioned medium by enzyme-linked immunosorbent assay as described in
the Methods section. Results are mean  SEM of four experiments (TIMP I)
and three experiments (TIMP II) each performed in quadruplicate.
(VLA-5), which binds to the arginine-glycine-aspartic
acid (RGD) sequence [27, 28], are found on activated
monocytes [29, 30]. The possible involvement of VLA-4
and VLA-5 was therefore investigated. Anti-VLA-4 and
VLA-5 antibodies caused a marked inhibition of U-937
and peripheral blood–derived monocyte adhesion to
whole matrix, suggesting that both cells shared common
binding mechanisms involving both integrins. However,
neither antibody completely blocked the adhesion pro-
cess, thereby indicating that other integrins and matrix
components, including collagen and laminin, may partici-
pate in this interaction. The demonstration of a commonFig. 7. Matrix metalloproteinase (MMP) release by monocytes cul-
tured in the presence of fibronectin. (A ) Peripheral blood–derived binding mechanism allowed us to use U-937 cells, which
monocytes (0.5  106 cells/mL) were co-incubated with increasing con- were more readily available than peripheral blood–centrations of fibronectin for 24 hours in the absence of fetal calf serum.
derived monocytes, for binding studies, although the lat-The resulting conditioned medium was subjected to zymography. Re-
sults are representative of two experiments. (B) Densitometric evalua- ter were employed to examine the effects of binding on
tion of zymograms shows the relative change in MMP secretion com- secretory function.pared to control (100%).
Chronic glomerular diseases are characterized by the
accumulation of extracellular matrix composed of pro-
teins, including collagens, laminin, and fibronectin, along
with proteoglycans and glycosaminoglycans. In the healthygial cells. Incubation of monocytes with mesangial matrix
and individual matrix proteins led to the secretion of glomerulus, these components not only provide struc-
tural support for glomerular cells but also influence theirproinflammatory cytokines (IL-1, IL-6, and TNF-)
and to the activation of MMP-9. The release of MMP-9 behaviour [31]. Fibronectin, one of the most abundant
mesangial matrix proteins, has been shown to have che-was not associated with a change in production of TIMPs.
By adding radiolabeled thymidine to monocytes incu- motactic properties for monocytes, macrophages, and
fibroblast and to be mitogenic to fibroblasts and mesan-bated with mesangial matrix we were able to demon-
strate that this increased secretion of cytokines and MMP gial cells [32]. Since our results demonstrate that individ-
ual matrix components differ in their ability to bind andwas not associated with cell proliferation. Our results,
therefore, suggest that accumulation of mesangial ma- activate macrophages, it follows that the nature of dis-
ease-related changes in matrix composition might, intrix, particularly fibronectin, promotes monocyte entrap-
ment and that binding to matrix proteins specifically turn, influence the extent of macrophage accumulation
within the diseased glomerulus and the secretory charac-stimulates monocyte secretion of inflammatory cytokines
and matrix degrading MMPs. Such interactions may have teristics of these infiltrating cells. Such interactions could
determine the outcome of an acute or chronic inflamma-important implications in the pathogenesis of renal in-
jury, particularly because the mechanisms by which mac- tory process.
Several animal and human studies suggests that mono-rophages are activated are known to determine their
functional characteristics [23]. cyte/macrophages play a critical role in the initiation and
progression of renal diseases. For example, in rats withBinding of monocytes to fibronectin is likely to be
mediated by integrin receptors, which are composed of remnant kidneys, macrophage accumulation was shown
to strongly correlate with the progression of focal sclero-the  and  subunits [24]. Among these integrins, 41
(VLA-4), which binds to the CS-1 and CS-5 regions sis suggesting that these cells may play a role in the
scarring process [4]. In humans, monocyte accumulationof the IIICS domain of fibronectin [25, 26], and 51
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is seen in most forms of glomerulonephritis, including ease-specific modification of matrix components may alter
monocyte/macrophage behavior and thereby potentiallythose associated with progressive fibrosis [33, 34]. While
monocyte infiltration may have beneficial functions, for influence disease outcome. For example, our results would
suggest that accumulation of fibronectin enhances MMPexample, promotion of the resolution of inflammation
by phagocytosis of apoptotic cells [35, 36], several mono- production, without increased inhibitor activity, a situa-
tion that is likely to promote matrix degradation. Inhibi-cyte/macrophage secretory products may have a detri-
mental influence on the function of adjacent mesangial tion of monocyte responses by blockade of these signal-
ing pathways represents a potential target for therapeuticcells. Our results demonstrate that binding of monocytes
to whole matrix and matrix proteins, particularly fibro- intervention in human glomerular disease and has proved
effective in recent animal studies [13].nectin, enhances secretion of proinflammatory cytokines
and matrix degrading MMPs. These findings are in agree-
ment with those of other investigators who have reported
CONCLUSION
enhanced monocyte secretion of IL-1, IL-6, IL-8, and
In summary, our results demonstrate that mesangialTNF- upon exposure of cells to matrix proteins, includ-
matrix plays a key role in the immobilization and activa-ing fibronectin [37–40]. For example, Takizawa et al [40]
tion of monocytes within the glomerulus. Since matrixdemonstrated that addition of fibronectin to monocytes
proteins differ in their ability to modulate monocyteisolated from human plasma stimulated production of
secretory functions, changes in matrix composition orIL-1, IL-6, and TNF-. There have also been reports of
organization in glomerular disease may influence thematrix proteins modulating secretion of MMPs by vari-
behavior of infiltrating cells and thereby the outcome ofous cells, including fibroblast [41] and keratinocytes [42].
the disease process. Better understanding of the poten-Recent studies from one of our group have demonstrated
tial importance of these processes may help in the designthat specific matrix components enhance secretion of
of treatment strategies for chronic glomerular diseases.MMP-2 and MMP-9 by human mesangial cells and that
membrane-type metalloproteinase (MTMMP), which is
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